Home/Pipeline/AMStent System

AMStent System

Malignant Pulmonary (Central Airway) Obstruction

Pre-clinicalActive

Key Facts

Indication
Malignant Pulmonary (Central Airway) Obstruction
Phase
Pre-clinical
Status
Active
Company

About Peytant Solutions

Peytant Solutions is a clinical-stage medical device company targeting a significant unmet need in oncology supportive care: the management of malignant airway obstructions. Its lead product, the AMStent System, is a self-expanding nitinol stent uniquely covered with a decellularized human amniotic membrane (DCAM), designed to elicit a reduced inflammatory and fibrotic response compared to standard covered stents. The company, founded by medtech veterans, has generated positive pre-clinical data and is advancing toward clinical trials. Peytant operates in the large and growing interventional pulmonology market, where current stent options are associated with high complication rates that its technology aims to address.

View full company profile